Stockholders' Equity - Schedule of Changes in Equity (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	$ 1,161	$ (2,106)
Settlement of liability awards	25	43
Vesting of RSUs, net of tax withholdings and other	(14)	(31)
Purchase of treasury stock	(28)	(51)
Purchase of SciPlay’s Class A common stock	(8)
Stock-based compensation	15	17
Net income	27	28
Other comprehensive income (loss)	6	(37)
Stockholders' equity, ending balance	1,184	(2,137)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	1	1
Stockholders' equity, ending balance	1	1
Additional Paid in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	1,370	1,337
Settlement of liability awards	25	43
Vesting of RSUs, net of tax withholdings and other	(14)	(31)
Purchase of SciPlay’s Class A common stock	(8)
Stock-based compensation	15	17
Stockholders' equity, ending balance	1,388	1,366
Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	517	(3,158)
Net income	22	26
Stockholders' equity, ending balance	539	(3,132)
Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	(580)	(175)
Purchase of treasury stock	(28)	(51)
Stockholders' equity, ending balance	(608)	(226)
Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	(318)	(261)
Other comprehensive income (loss)	6	(37)
Stockholders' equity, ending balance	(312)	(298)
Noncontrolling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	171	150
Net income	5	2
Stockholders' equity, ending balance	$ 176	$ 152